Resverlogix Corp T.RVX

Alternate Symbol(s): RVXCF

Healthcare Biotechnology

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.

TSX:RVX - Post by User

Resverlogix Corp

Bullboard Posts

Comment by amorakon Sep 28, 2011 10:54am

228 Views

Post# 19092930

RE: RE: RE: Amorak

We manic depressives now are considered to have bipolar disorder. Naming it that isn't quite so, um, depressing!
.
Have a look at your post #30211962 on Sept 22..
.
Did you post it because you:
.
a) Agree with it.
b) Disagree with it.
.
Please check one.
.
And how about post #30223757 where you say you were a publisher but that I can't write well enough to be employed by you.
.
Which is it, my posts are so good they must come from published material or they're so bad they couldn't be published. .
Which is it?
.
Should I post where you pronounce RVX to be lying? Do you want that one again?
.

Bullboard Posts

Understanding tax loss season and the “Santa Claus rally”